Karim Belhadj - From the Laboratoire Merrel Dow, Paris, France

基本信息

浏览量：90

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 104 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor

Anaïs Schavgoulidze,Alexis Talbot,Aurore Perrot, Titouan Cazaubiel, Xavier Leleu,Salomon Manier,Laure Buisson, Sabrina Mahéo, Laura Do Souto Ferreira, Luka Pavageau, Cyrille Hulin, Jean-Pierre Marolleau,

Blood（2023）

引用2浏览0WOS引用

Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study

Fabio Andreozzi,Matteo Dragani,Cyril Quivoron,Fabien Le Bras,Tarek Assi,Alina Danu,Karim Belhadj,Julien Lazarovici,Sophie Cotteret,Olivier A Bernard, Vincent Ribrag,Jean-Marie Michot

Cancersno. 5 (2023)

引用0浏览0WOS引用

Outcome of Patients with Primary Mediastinal Large B-Cell Lymphoma after R-CHOP21, R-CHOP14 and R-ACVBP: A Pooled Analysis of Clinical Trials from Lysa

David Sibon,Christian Gisselbrecht,Thierry Jo Molina,Vincent Camus, Olivier Casasnovas,Christian Recher,Nicolas Ketterer, Olivier Fitoussi,Karim Belhadj,Julie Bruneau, Marie Parrens,Jean-François Emile,

Blood (2022): 1082-1084

引用0浏览0引用

Thrombospondin type-1 domain-containing 7A-related membranous nephropathy associated with glomerular AL amyloidosis

Antoine Morel,David Buob,Jean-Michel Goujon,Karim Belhadj,Marie-Christine Verpont,Vincent Audard,Anissa Moktefi

Pathology（2022）

引用0浏览0WOS引用

Heterogeneity in long term outcomes for R-ISS stage II in newly diagnosed multiple myeloma patients

Anais Schavgoulidze,Valerie Lauwers-Cances,Aurore Perrot, Titouan Cazaubiel,Marie-Lorraine Chretien, Philippe Moreau,Thierry Facon, Xavier Leleu, Lionel Karlin, Anne-Marie Stoppa, Olivier Decaux,Karim Belhadj,

Haematologica（2022）

引用5浏览0WOS引用

Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies

Simon B Gressens,Slim Fourati, Anne Le Bouter,Fabien Le Bras, Jehan Dupuis,Mohammad Hammoud,Taoufik El Gnaoui, Romain Gounot,Louise Roulin,Karim Belhadj,Corinne Haioun,Sébastien Gallien,

Clinical Microbiology and Infection（2022）

引用8浏览0WOS引用

Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study

Murielle Roussel,Valérie Lauwers-Cances, Margaret Macro,Xavier Leleu,Bruno Royer, Cyrille Hulin, Lionel Karlin,Aurore Perrot,Cyrille Touzeau, Marie-Lorraine Chrétien, Sophie Rigaudeau, Mamoun Dib,

Blood（2022）

引用9浏览0WOS引用

Effectiveness And Safety Of Subcutaneous Rituximab For Patients With Gastric Malt Lymphoma: A Case-Control Comparison With Intravenous Rituximab

Hugo Rotkopf,Michaël Lévy,Christiane Copie-Bergman,Jehan Dupuis, Muriel Verlinde-Carvalho,Emmanuel Itti,Charlotte Gagniere,Karim Belhadj,Jenny Tannoury,Fabien Le Bras,Iradj Sobhani,Corinne Haioun,

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2021）

引用0浏览0WOS引用

Up-Front Carfilzomib, Lenalidomide, And Dexamethasone With Transplant For Patients With Multiple Myeloma: The Ifm Krd Final Results

Murielle Roussel,Valerie Lauwers-Cances,Soraya Wuilleme,Karim Belhadj,Salomon Manier,Laurent Garderet, Martine Escoffre-Barbe, Slara Mariette, Lotfi Benboubker, Denis Caillot, Cécile Sonntag,Cyrille Touzeau,

BLOOD（2021）

引用17浏览0WOS引用

Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation

Clarisse Cazelles,Karim Belhadj, Hélène Vellemans, Vincent Camus,Elsa Poullot,Philippe Gaulard, Liana Veresezan,Emmanuel Itti, Stéphanie Becker, Muriel Carvalho, Jehan Dupuis,Fabien Le Bras,

LEUKEMIA & LYMPHOMA（2021）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn